SLC3A2 and central nervous system cancer: Consistent with the TCGA and GEO database findings, an upregulation of SLC3A2 was observed in glioma tissues in our collection of 24 paired tumor and adjacent non-tumor tissues from glioma patients (Fig. 2F-G).